Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie

7680690390044 CH-69039 Lösung
Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie
Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie
Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
06/02/2025
Summary of Product Characteristics
Français
06/02/2025
Summary of Product Characteristics
Italien
06/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 395.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2024

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
69039
Drug name
Beyfortus, solution injectable en seringue préremplie
Galenic form
INLFS
ATC Code
J06BD08
Authorization status
Z
Dispensing category
A
First authorization
22/12/2023
Authorization expiration date
21/12/2028
IT Number
08.03.0.
Domain
Human medicine
Field of application
RSV-Prophylaxe

Package details

Description (FR)
BEYFORTUS sol inj 100 mg/ml 2 aiguilles ser pré
Description (DE)
BEYFORTUS Inj Lös 100 mg/ml 2 Nadeln Fertspr
Market launch
22/12/2023
Narcotic (BTM)
No

Other package sizes (3)

None
1 FESP
GTIN: None
Not in V1
BEYFORTUS sol inj 50 mg/0.5ml 2 aiguilles ser pré
1 FESP
GTIN: 7680690390020
View
None
1 FESP
GTIN: None
Not in V1